Vietnam Active Pharmaceutical Ingredients Research

7 comprehensive market analysis studies and research reports on the Vietnam Active Pharmaceutical Ingredients sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 1625 companies, enriched with industry statistics, insights, and a lot more.

Vietnam Active Pharmaceutical Ingredients Industry Mordor Intelligence

TRENDING REPORTS

CAGR: 7.25%
Study Period: 2020 - 2031
CAGR: 3.62%
Study Period: 2020 - 2031
CAGR: 4.62%
Study Period: 2020 - 2031
CAGR: 7.45%
Study Period: 2020 - 2031
CAGR: 7.66%
Study Period: 2020 - 2031

Dots and Lines - Pattern
7 Healthcare Reports
APAC Biguanide Market Major Players
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Starting at:$4,750
Sulfonylureas Market Major Players
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Starting at:$4,750
Meglitinide Market Major Players
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Starting at:$4,750
Alpha-glucosidase Inhibitors Market Major Players
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Starting at:$4,750
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market Major Players
Country Covered: Vietnam
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Starting at:$4,750
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players
Country Covered: Vietnam
Major Players:AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon
Starting at:$4,750
Asia-Pacific Insulin Therapeutics Market Major Players
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Starting at:$4,750
Dots and Lines - Pattern
CONTACT US

When decisions matter, industry leaders turn to our analysts. Let’s talk.

🌐Country code
down